STOCK TITAN

Therma Bright Inc - TBRIF STOCK NEWS

Welcome to our dedicated news page for Therma Bright (Ticker: TBRIF), a resource for investors and traders seeking the latest updates and insights on Therma Bright.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Therma Bright's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Therma Bright's position in the market.

Rhea-AI Summary
Therma Bright Inc. (TBRIF) initiates a strategic review process to enhance shareholder value. The Board will explore various alternatives, including strategic partnerships, acquisitions, or spin-offs. The company also finalizes an 8.44% equity holding in Inretio for its Preva™ Ischemic stroke device.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-24.67%
Tags
none
-
Rhea-AI Summary
Therma Bright Inc. (TBRIF) will resume trading on the TSXV on February 7, 2024. The company received a letter from the Center of Medicare and Medicaid regarding its Venowave device, confirming the reopening of its application for securing permanent CPT/HCPCS codes. This is a positive development for the company's medical device technologies. Additionally, Therma Bright has received notification from the TSXV about the resumption of stock trading.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30.77%
Tags
none
-
Rhea-AI Summary
Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) has received a cease trade order from the Ontario Securities Commission for not filing annual financial statements and management's discussion and analysis by the periodic disclosure deadline. The company is working with its new auditor to finalize the documents and aims to file them soon, expecting no lengthy delay.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-26.09%
Tags
none
Rhea-AI Summary
Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) has announced that its AI-driven Digital Cough Analyzer (DCA) developed in partnership with AI4LYF, is ready for a 513(g) request to the U.S. FDA. The DCA offers advanced features for patients and medical practitioners, aiming to revolutionize remote therapeutic monitoring (RTM) solutions. The technology has the potential to diagnose various health issues through cough data analysis, making it a groundbreaking innovation in healthcare.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
AI
-
Rhea-AI Summary
Therma Bright Inc. has opened its distribution channels for its Venowave device, with multiple partners expressing interest in evaluating its commerciality. Pilot units have been shipped to each partner for patient pilot tests.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.35%
Tags
none
-
News
Rhea-AI Summary
Therma Bright Inc. appoints Eric Myung as CFO, replacing Victor Hugo. Myung has extensive experience in financial analysis and has worked as CFO for several TSX Venture Exchange companies. The CEO welcomes Myung and Marrelli Support Services to the team.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Therma Bright Inc. announces change of auditors from HS & Partners LLP to Zeifmans LLP. Former Auditor terminated and Successor Auditor appointed effective February 22, 2023. Change of auditor approved by board of directors and audit committee. No reservations or reportable events. Appointment of Successor Auditor to be brought before next shareholders' meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Therma Bright Inc. announces amended agreement to acquire 25% interest in InStatin and InVixa, with an option to acquire additional shares. Therma will issue 55,000,000 shares to the Vendors in exchange for shares in InVixa and InStatin. Therma also has the option to purchase more shares in InStatin for up to $499,997.08.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-38.1%
Tags
-
Rhea-AI Summary
Therma Bright Inc. announces partnership with Hero LifeCare for distribution of Venowave device in the U.S.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Therma Bright Inc. submits updated FDA 510K application for Venowave device, aiming to secure permanent CPT and HCPCS codes
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Therma Bright Inc

OTC:TBRIF

TBRIF Rankings

TBRIF Stock Data

3.46M
300.45M
4.9%
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Wholesale Trade
Link
Canada
Toronto